Previous 10 |
No IPOs are scheduled for the week ahead, unusual for mid-March. It may be due to some lingering effects from the government shutdown, as the SEC works through its backlog. With the VIX Volatility Index comfortably below 20 and strong YTD returns in the IPO Index, the IPO market is receptive...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
111, Inc. (YI) Q4 2018 Earnings Conference Call March 07, 2019 07:30 AM ET Company Participants Monica Mu - IR, Director Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO Harvey Wang - Co-COO Barry Zhu - Co-COO Alex...
111 (NASDAQ: YI ): Q4 Non-GAAP EPS of -$0.19; GAAP EPS of -$0.22. More news on: 111, Earnings news and commentary, Consumer stocks news, Read more ...
SHANGHAI, China, March 07, 2019 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2018. Four...
SHANGHAI, China, Feb. 27, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (Nasdaq: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that Mr. Yang Chen has been appointed as Chief Financial Officer, effective immediately on February 27, 2019. B...
SHANGHAI, China, Feb. 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December...
SHANGHAI, China, Jan. 28, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced it has signed a strategic cooperation memorandum of understanding with Eli Lilly and C...
News, Short Squeeze, Breakout and More Instantly...
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow PR Newswire SHANGHAI , April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company co...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire SHANGHAI , March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting p...